The Post-transplant Lymphoproliferative Disorders-Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) Study Methods...

Area of Science:

• Virology
• Oncology
• Transplantation Medicine

Background:

• Post-transplant lymphoproliferative disorders (PTLDs) are significant transplant complications with high mortality.
• Epstein-Barr virus (EBV) drives 50-80% of PTLDs, but prognostic factors remain inconsistent.
• Limited tools exist to assess pathogenic viral genome variants, especially in EBV-negative PTLDs.

Purpose of the Study:

• To validate anellovirus as a biomarker for increased mortality in PTLD patients.
• To identify other oncogenic viruses contributing to EBV-negative PTLD.
• To develop computational tools for analyzing Epstein-Barr virus genome variants in PTLD outcomes.

Main Methods:

• Utilizing metagenomic shotgun sequencing (MSS) on PTLD tissues and plasma.
• Employing novel technologies for unbiased screening of all vertebrate viruses.
• Confirming viral findings with Polymerase Chain Reaction (PCR) and other techniques.

Main Results:

• Anellovirus positivity in PTLD tissue, confirmed by PCR, correlates with higher transplant recipient mortality.
• Ongoing research aims to identify other viral agents in EBV-negative PTLDs.
• Development of analytical tools to link EBV genome variants to PTLD presentation and outcomes is underway.

Conclusions:

• Metagenomic shotgun sequencing offers a powerful approach to understanding viral roles in PTLDs.
• Identifying specific viral biomarkers like anellovirus can improve PTLD patient prognostication.
• Further research into viral genome variants and their pathogenic roles may lead to novel therapeutic strategies for PTLDs.